ALLIANCE FOR CANCER GENE THERAPY INC
Data sourced from IRS 990 public filings
ALLIANCE FOR CANCER GENE THERAPY INC ALLIANCE FOR CANCER GENE THERAPY (ACGT) FUNDS THE MOST INNOVATIVE SCIENTISTS (CONTINUED IN SCH O) WORKING TO HARNESS THE POWER OF CELL AND GENE THERAPY TO TRANSFORM HOW CANCER IS TREATED AND DRIVE MOMENTUM TOWARD A CURE.
Annual Revenue
$3,103,520
Known Funders
27
Grants Received
54
Financial History
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2024 | $3,103,520 | $5,355,546 | $15,733,028 |
| 2023 | $9,059,178 | $1,966,204 | $15,042,870 |
| 2022 | $3,231,770 | $2,498,579 | $7,929,383 |
| 2021 | $3,295,905 | $1,804,221 | $7,018,537 |
| 2020 | $1,716,695 | $2,586,563 | $6,851,434 |
Top Funders
Charlotte, NC
Charlotte, NC
NEW YORK, NY
NEW YORK, NY
Boston, MA
Boston, MA
Boston, MA
Boston, MA
SAN DIEGO, CA
SAN DIEGO, CA
Showing top 10 of 27 funders.
Key Personnel
From 2024 IRS 990 filing
KEVIN HONEYCUTT
CEO & PRESIDENT
MARC ENGELSGJERD MD
DIRECTOR (EFF 12/5/24)
DANIEL ENGLANDER
DIRECTOR
MARIA FARDIS PHD
DIRECTOR
PETER A GLICKLICH ESQ
DIRECTOR
MICHAEL GREGORY
DIRECTOR
CHAU Q KHUONG
DIRECTOR
JOHN LAHEY PHD
DIRECTOR
ALEXANDRA LANDES
DIRECTOR
BRUCE L LEVINE PHD
DIRECTOR
Showing 10 of 21 key personnel.
Frequently Asked Questions
Other Nonprofits in Connecticut
Unlock Full Nonprofit Data
Sign up for free to access the complete funder list, financial history, program details, key personnel, and smart matching.